
Three divisions. One mission. From patient diagnosis to AI-powered lab automation to life science research — Hybrinomics is building the future of healthcare.
Explore Our Divisions
Guided, standardized scoring for PD-L1, HER2, MMR, ER/PR/Ki-67 and p53 — reference-backed and consistent, with cut-offs each lab can fine-tune.
A bench-tablet workflow from grossing to embedding to cutting — container and cassette tracking, technical traceability and biobank-linked labels.
Scan glass slides into high-resolution digital slides — zoom, annotate and measure, with secure remote review and patient sharing via HybriScope.
The Hybrinomics group was founded by Dr. Prabhu Meganathan, a practicing pathologist, researcher, and innovator, with a vision to bridge the gap between clinical diagnostics, intelligent automation, and life science research. What began as a single histopathology laboratory has grown into three specialized divisions — each advancing a different frontier of healthcare.